PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair

MLA

Jos Jonkers, et al. “PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair.” Cancers, vol. 13, no. 14, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0760a1448b21e23da4e0b92d08fb949e&authtype=sso&custid=ns315887.

APA

Jos Jonkers, Anna Huguet Ninou, Emma Åkerlund, Ulrika Joneborg, Dimitrios Chioureas, Joseph W. Carlson, Brinton Seashore-Ludlow, Hannah Stigsdotter, Korbinian Schelzig, Nina M. S. Gustafsson, Greta Gudoityte, & Jemina Lehto. (2021). PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair. Cancers, 13(14).

Chicago

Jos Jonkers, Anna Huguet Ninou, Emma Åkerlund, Ulrika Joneborg, Dimitrios Chioureas, Joseph W. Carlson, Brinton Seashore-Ludlow, et al. 2021. “PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair.” Cancers 13 (14). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0760a1448b21e23da4e0b92d08fb949e&authtype=sso&custid=ns315887.